Sale of PerClot (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 28, 2021	Jan. 31, 2026	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Disposal Group, Including Discontinued Operations [Line Items]
Total revenues			$ 125,757	$ 112,972	$ 242,094	$ 211,950
Per Clot
Disposal Group, Including Discontinued Operations [Line Items]
Consideration for sale of assets	$ 41,000						$ 5,000
Total revenues			1,900	$ 1,000	2,400	$ 1,800
Gain from sale of non-financial assets							7,000
Notes and loans receivable			5,000		5,000		5,000
Per Clot | Transfer Of Perclot Manufacturing Equipment
Disposal Group, Including Discontinued Operations [Line Items]
Contingent consideration receivable	800
Per Clot | Upon Our Receipt of Premarket Approval
Disposal Group, Including Discontinued Operations [Line Items]
Proceeds from sale of assets	18,800
Per Clot | Starch Medical Inc.
Disposal Group, Including Discontinued Operations [Line Items]
Contingent liability payment	4,500	$ 1,500
Payable			$ 1,500		$ 1,500		$ 3,000
Per Clot | Artivion Inc. And Starch Medical Inc.
Disposal Group, Including Discontinued Operations [Line Items]
Consideration for sale of assets	54,500
Proceeds from sale of assets	25,000
Per Clot | Artivion Inc. And Starch Medical Inc. | Baxter Achievement Of Worldwide Sales
Disposal Group, Including Discontinued Operations [Line Items]
Contingent consideration receivable	$ 10,000
Contractual period	24 months
Per Clot | Starch Medical Inc.
Disposal Group, Including Discontinued Operations [Line Items]
Consideration for sale of assets	$ 13,500
Contingent liability payment	6,000
Per Clot | Starch Medical Inc. | Baxter Achievement Of Worldwide Sales
Disposal Group, Including Discontinued Operations [Line Items]
Contingent liability payment	$ 3,000